|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Leptin : physiological actions 显示文摘 | Marti A Berraondo B | 1999 | Physiol Biochem1999，55，： | 1 |
| 2 | IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus:differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes显示文摘 | Berraondo P Ochua L Crettaz J | 2005 | Mol Ther2005，12，1： | 1 |
| 3 | IFN-alpha gene therapy for woodchuck hepatitis with adeno-assoeiated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes 显示文摘 | Berraondo P Oehoa L Crettaz J | 2005 | Mol Ther2005，12，1： | 1 |
| 4 | Cytokines for the treatment of gastrointestinal cancers:clinical experience and new perspectives显示文摘 | Hernandez-Alcoceba R Sangro B Berraondo P | 2013 | Expert Opin Investig Drugs2013，22，7： | 1 |
| 5 | Upregulation of muscle UCP2 gene expression by a new 3-adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but down-regulation in lean animals 显示文摘 | B Berraondo A Marti J S Duncan | 2004 | International Journal of Obesity2004，2，24： | 1 |
| 6 | Immunochemotherapy against colon cancer by gene transfer of interleukin-12 in combination with oxaliplatin显示文摘 | Hernandez-Alcoceba R Berraondo P | 2012 | Oncoimmunology2012，1，1： | 1 |
| 7 | Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system显示文摘 | BERRAONDO P NOUZE C PREVILLE X | 2007 | Cancer Res2007，67，18： | 1 |
| 8 | Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin 显示文摘 | Mansilla C Berraondo P Casares N | 2012 | Int J Cancer2012，131，： | 1 |
| 9 | IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportaI or intramuscular routes显示文摘 | BERRAONDO P OCHOA L CRETTAZ J | 2005 | Mol Ther2005，12，1： | 1 |
| 10 | Antitumoral efficacyof DNA nanoparticles in murine models of lung cancer and pulmonarymetastasis显示文摘 | Rodrigo-Garzon M Berraondo P Ochoa L | 2010 | Cancer Gene Therapy2010，17，1： | 1 |
| 11 | Immunochemothera-py against colon cancer by gene transfer of interleukin-12in combination with oxaliplatin 显示文摘 | Hernandez-Alcoceba R Berraondo P | 2012 | Oncolmmunology2012，1，： | 1 |
| 12 | Advances in interleukin-12 gene therapy for acquired liver diseases 显示文摘 | Berraondo P Prieto J Gonzalez-Aseguinolaza G | 2009 | Curr Gene Ther2009，9，2： | 1 |
| 13 | Advances in interleukin-12 gene therapy for acquired liver diseases显示文摘 | Berraondo P Prieto J Gonzalez-Aseguinolaza G | 2009 | Curr Gene Ther2009，9，2： | 1 |
| 14 | Induction of gp120-specif-ic protective immune responses by genetic vaccination with linear- polyethylenimine-plasmid complex 显示文摘 | Garzon MR Berraondo P Crettaz J | 2005 | Vaccine2005，23，11： | 1 |
| 15 | Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin显示文摘 | Mansilla C Berraondo P Durantez M | 2012 | Int J Cancer2012，131，3： | 1 |
| 16 | Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex显示文摘 | Garzon MR Berraondo P Crettaz J | 2005 | Vaccine2005，23，11： | 1 |
| 17 | Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice显示文摘 | Crettaz J Berraondo P Mauleon I | 2006 | Hepatology2006，44，： | 1 |
| 18 | Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin显示文摘 | Mansilla C Berraondo P Durantez M | | 0，，： | 1 |
| 19 | Leptin: physiologicalactions 显示文摘 | Marti A Berraondo B Martinez JA | 1999 | Physiol Biochem1999，55，1： | 1 |
| 20 | Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms显示文摘Gene engineering and combinatorial approaches with other cancer immunotherapy agents may confer capabilities enabling full tumor rejection by adoptive T cell therapy(ACT).The provision of proper costimulatory receptor activity and cytokine stimuli,along with the repression of inhibitory mechanisms,will conceivably make the most of these treatment strategies.In this sense,T cells can be genetically manipulated to become refractory to suppressive mechanisms and exhaustion,last longer and differentiate into memory T cells while endowed with the ability to traffic to malignant tissues.Their antitumor effects can be dramatically augmented with permanent or transient gene transfer maneuvers to express or delete/repress genes.A combination of such interventions seeks the creation of the ultimate bionic T cell,perfected to seek and destroy cancer cells upon systemic or local intratumor delivery. | Iñaki Etxeberria Irene Olivera Elixabet Bolaños Asunta Cirella Álvaro Teijeira Pedro Berraondo Ignacio Melero | 2020 | Cellular & Molecular Immunology2020，17，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员